Processing your payment...
Please do not close your browser.

Basal Cell Carcinoma Treatment Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players: Roche, Sun Pharmaceuticals, Bausch Health Companies, Taro Pharmaceuticals, Mylan

27 Jun, 2022 | 166 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Basal Cell Carcinoma Treatment Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 9.8 % during the review period (2022 to 2029).

 Basal Cell Carcinoma Treatment Market Overview

Basal cell carcinoma (BCC) is the most prevalent type of skin cancer, as well as the most common type of cancer overall. Each year, more than 4 million cases are identified in the United States alone. Basal cell carcinomas (BCCs) are caused by the uncontrolled development of basal cells. This is because to BCCs' sluggish growth, which is usually treatable and causes little damage if discovered and treated early. Understanding the origins, risk factors, and warning symptoms of BCC can aid in early detection, when it is easier to treat and cure.

The key factors influencing the market are an increase in various types of skin issues and an increase in the recurrence of cuticular malignancies. In addition, the growing senior population, rising recurrence rates, and patient-centered repayment options are all boosting the growth of the basal cell carcinoma therapy market. The fundamental causes of skin diseases include increasing frequency in skin growths as a result of various environmental factors such as UV exposure from the sun. In addition, the eventual outcomes of treatment and the time it takes for pharmaceuticals to be approved are factors impacting the market's development.

In recent years, the market has grown due to rising incidences of Basal cell carcinoma among the senior population, changing lifestyle of the urban population living in developed countries, and improved awareness about the disease's recurrence rate and progression.

What is our Basal Cell Carcinoma Treatment Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 9.8 % during the review period (2022 to 2029).

 

By Type

  • Topical Treatment
  • Hedgehog Pathway Inhibitor Therapy
  • Mohs Surgery
  • Other Surgeries
  • Other Treatments

 

By Application

  • Hospitals
  • Specialty Clinics
  • Others

 

 By Companies

 

 

 

 

Roche, Sun Pharmaceuticals, Bausch Health Companies, Taro Pharmaceuticals, Mylan

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

166

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Basal Cell Carcinoma Treatment Market?

The Basal Cell Carcinoma Treatment Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Roche, Sun Pharmaceuticals (NSE: SUNPHARMA), Bausch Health Companies, Taro Pharmaceuticals (NYSE: TARO), Mylan (NASDAQ: VTRS) and others.

Industry News:

In May 2020, Sanofi announced that its Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma.

27 July 2021: Merck & Co., Inc., announced that the US Food and Drug Administration (USFDA) approved “KEYTRUDA, Merck’s anti-PD-1 therapy”, as mono therapy for the treatment of patients suffering from recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation.)

In June 2020, Sun Pharmaceutical Industries Ltd announced that the “USFDA has approved its two specialty medicines-ODOMZO® (sonidegib) and LEVULAN® KERASTICK® (aminolevulinic acid HCl) + BLU-U®” from its dermatology portfolio. The company provides insights to the healthcare providers treating patients suffering from high risk for different types of cancers.

What are the major Applications, Types and Regions for Basal Cell Carcinoma Treatment Market?

By Type, it is segmented into

  • Topical Treatment

  • Hedgehog Pathway Inhibitor Therapy

  • Mohs Surgery

  • Other Surgeries

  • Other Treatments

By Applications it is segmented into

  • Hospitals

  • Specialty Clinics

  • Others

Basal Cell Carcinoma Treatment Market Regional Analysis

In the worldwide basal cell carcinoma market, North America has the largest share. Because of the high occurrence of basal cell carcinoma, there is a strong demand for a variety of treatment alternatives. This is one of the most important reasons driving the global basal cell carcinoma therapy market. Aside from that, the basal cell carcinoma market in Asia-Pacific is expected to expand at a faster rate in the approaching years, with a phenomenal CAGR.

On the other hand, due to considerable income generation from the Australian region, the market in Asia Pacific is predicted to rise significantly throughout the projection period. The Australian government supports providing skin malignant growth occurrences instruction in schools. Because Australia has the highest rate of skin tumours on the planet, it has previously been effective in decreasing the prevalence of such malignant growth, and with additional support, it is anticipated to improve over time.

The market for Basal Cell Carcinoma Treatment in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Basal Cell Carcinoma Treatment Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Basal Cell Carcinoma Treatment Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Topical Treatment, Hedgehog Pathway Inhibitor Therapy, Mohs Surgery, Other Surgeries, Other Treatments) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Hospitals, Specialty Clinics, Others.) 2021/2022
    4. Impact of COVID-19 on the Basal Cell Carcinoma Treatment Market
    5. Production Share of Basal Cell Carcinoma Treatment, By Region, 2022
    6. Key Industry Developments
  5. Global Basal Cell Carcinoma Treatment Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Hospitals
      2. Specialty Clinics
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Topical Treatment
      2. Hedgehog Pathway Inhibitor Therapy
      3. Mohs Surgery
      4. Other Surgeries
      5. Other Treatments
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Roche
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Sun Pharmaceuticals
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Bausch Health Companies
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Taro Pharmaceuticals
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla